| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 298.77▼ | 298.04▲ | 298.44▼ | 291.10▲ | 286.46▲ |
| MA10 | 299.00▼ | 298.59▼ | 298.20▲ | 286.24▲ | 289.44▲ |
| MA20 | 298.10▲ | 297.41▲ | 294.12▲ | 286.11▲ | 278.95▲ |
| MA50 | 298.67▼ | 291.12▲ | 284.87▲ | 290.91▲ | 231.53▲ |
| MA100 | 297.92▲ | 284.65▲ | 285.58▲ | 273.64▲ | 177.80▲ |
| MA200 | 294.05▲ | 285.42▲ | 285.86▲ | 237.56▲ | 126.90▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.060▲ | -0.482▼ | -0.017▼ | 1.851▲ | -3.229▼ |
| RSI | 48.011▼ | 58.003▲ | 63.342▲ | 60.085▲ | 65.874▲ |
| STOCH | 48.785 | 39.494 | 71.014 | 67.087 | 30.753 |
| WILL %R | -54.035 | -54.966 | -24.864▲ | -10.446▲ | -34.779 |
| CCI | -33.275 | -27.949 | 52.095 | 181.999▲ | -1.248 |
| ▲ MACD | $LGND MACD(12,26,9) Crossed Above Zero | Set Alert |
|
Tuesday, September 22, 2026 06:05 AM
Sydnexis, Inc. has agreed to sell its royalty rights for Ryjunea® in Europe, the Middle East, and Africa to Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) for $23 million ...
|
|
Tuesday, September 22, 2026 05:19 AM
Ligand agreed to acquire royalty and milestone rights for Santen’s Ryjunea eye drop for $23 million upfront, expanding its royalty portfolio.
|
|
Tuesday, September 22, 2026 04:00 AM
Ryjunea is the first and only pharmacologic treatment approved by the European Commission and UK MHRA to slow myopia progression in pediatric patients Ligand will receive a tiered low-double-digit to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/09/26 | 300.02 | 301.45 | 295.61 | 298.24 | 208,672 |
| 22/09/26 | 290.72 | 300.32 | 288.54 | 298.87 | 172,899 |
| 21/09/26 | 283.67 | 290.51 | 282.45 | 290.07 | 237,400 |
| 18/09/26 | 285.63 | 285.64 | 280.49 | 283.49 | 372,800 |
| 17/09/26 | 281.31 | 285.34 | 277.825 | 284.84 | 200,562 |
| 16/09/26 | 277.97 | 278.74 | 271.22 | 275.20 | 299,000 |
| 15/09/26 | 278.32 | 279.25 | 270.72 | 277.30 | 143,656 |
| 14/09/26 | 284.93 | 287.14 | 280.12 | 280.65 | 158,800 |
| 11/09/26 | 291.48 | 294.00 | 283.77 | 284.47 | 261,200 |
| 10/09/26 | 285.00 | 291.26 | 283.04 | 289.25 | 146,600 |
|
|
||||
|
|
||||
|
|